Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Gale, Edwin Am"'
Autor:
Beran, David, Abidha, Carol, Adler, Amanda, de Beaufort, Carine, Lepeska, Molly, Levitt, Naomi, Pfiester, Elizabeth, Zafra Tanaka, Jessica Hanae, Gale, Edwin Am
Publikováno v:
The Lancet Diabetes & Endocrinology. 11:78-80
The US Food and Drug Administration's (FDA) approval of teplizumab to delay the onset of type 1 diabetes could be seen as symbolic, because it came a century after the first use of insulin. Teplizumab, an anti-CD3 monoclonal antibody, is now approved
Autor:
Gale, Edwin AM
Publikováno v:
BMJ: British Medical Journal, 2011 Oct . 343(7827), 754-755.
Externí odkaz:
https://www.jstor.org/stable/23052041
Autor:
Gale, Edwin AM
Publikováno v:
In The Lancet 20 March 2004 363(9413):925-931
Autor:
Gale, Edwin AM
Publikováno v:
In Clinical Medicine November 2003 3(6):538-541
Autor:
Gale, Edwin AM, Anderson, John V
Publikováno v:
In Kumar & Clark's Clinical Medicine Edition: Ninth Edition. 2017:1277-1291
Autor:
Gale, Edwin AM, Anderson, John V
Publikováno v:
In Kumar & Clark's Clinical Medicine Edition: Ninth Edition. 2017:1241-1276
Autor:
Gale, Edwin AM
Publikováno v:
In The Lancet 2001 357(9271):1870-1875
Autor:
Gillespie, Kathleen M, Bain, Steven C, Barnett, Anthony H, Bingley, Polly J, Christie, Michael R, Gill, Geoffrey V, Gale, Edwin AM
Publikováno v:
In The Lancet 2004 364(9446):1699-1700
Publikováno v:
Butler, PC; Elashoff, M; Elashoff, R; & Gale, EAM. (2013). A critical analysis of the clinical use of incretin-based therapies are the GLP-1 therapies safe?. Diabetes Care, 36(7), 2118-2125. doi: 10.2337/dc12-2713. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1tk3q0t9
Diabetes care, vol 36, iss 7
Diabetes care, vol 36, iss 7
There is no question that incretin-based glucose-lowering medications have proven to be effective glucose-lowering agents. Glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate an efficacy comparable to insulin treatment and appear to do so w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b174b13d2daa4617c9d69ec3b3768378
http://www.escholarship.org/uc/item/1tk3q0t9
http://www.escholarship.org/uc/item/1tk3q0t9
Autor:
Gale, Edwin AM1 Edwin.Gale@bristol.ac.uk
Publikováno v:
Lancet. 11/11/2006, Vol. 368 Issue 9548, p1626-1628. 3p.